Biopassport (BIOT) recently unveiled its ambitious roadmap for 2025, highlighting significant expansion plans in the field of Artificial Intelligence (AI). According to the roadmap published on Medium, the company aims to enhance its AI capabilities in various healthcare sectors throughout the year. In the first quarter, Biopassport plans to focus on AI data mapping and learning within the healthcare industry. This will involve leveraging AI algorithms to analyze and interpret complex healthcare data, enabling better decision-making and personalized patient care. The second quarter will witness an upgrade to the company's AI version and the construction of a user blockchain. The upgraded AI version will incorporate advanced machine learning models to improve the accuracy and efficiency of its AI-powered solutions. The user blockchain will provide a secure and decentralized platform for managing and sharing healthcare data. During the third quarter, Biopassport intends to launch an AI chatbot business. This chatbot will serve as a virtual assistant, providing personalized health information and support to patients and healthcare professionals. The chatbot will be integrated with the company's AI-powered healthcare platform, offering a seamless user experience. In the final quarter of 2025, the company plans to expand its AI-related linkage business. This will involve establishing partnerships with other healthcare providers and organizations to integrate its AI solutions into their systems. By expanding its reach, Biopassport aims to make its AI-powered healthcare services accessible to a wider audience. Biopassport's roadmap underscores its commitment to innovation and the advancement of AI in healthcare. The company's planned expansion in this area positions it as a key player in the digital health revolution, empowering healthcare professionals and patients alike with cutting-edge AI technology.